Interference Study

Cambridge, Massachusetts, August 3, 2026 Akebia Therapeutics, Inc. announced the initiation of an open-label Phase 2 basket trial of...

New York, August 3, 2026 Intelligent Bio Solutions Inc. (INBS) announced the completion of an Interference Study for its...